Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p74
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 74/191)
Character Range: 10347962–10359893

be in combination with a 5-hydroxytryptamine receptor (5HT3) antagonist and dexamethasone on day 1 of a chemotherapy cycle; AND
                                                                                                                                                                                                                               Patient must be scheduled to be administered a chemotherapy regimen that includes either carboplatin or oxaliplatin.
                                                                                                                                                                                                                               No more than 1 vial of fosaprepitant 150 mg injection will be authorised per cycle of cytotoxic chemotherapy.
                                                                                                                                                                                                                               Concomitant use of a 5HT3 antagonist should not occur with fosaprepitant on days 2 and 3 of any chemotherapy cycle.
C6860               P6860          CN6860           Glatiramer                                                                                                                                                                 Multiple sclerosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Compliance with Authority Required procedures - Streamlined Authority Code 6860
                                                                                                                                                                                                                               Continuing treatment
                                                    Interferon beta-1b                                                                                                                                                         The condition must be diagnosed as clinically definite relapsing-remitting multiple sclerosis; AND
                                                                                                                                                                                                                               Patient must have previously received PBS-subsidised treatment with this drug for this condition; AND
                                                    Peginterferon beta-1a                                                                                                                                                      Patient must not show continuing progression of disability while on treatment with this drug; AND
                                                                                                                                                                                                                               Patient must have demonstrated compliance with, and an ability to tolerate this therapy.
C6871               P6871          CN6871           Varenicline                                                                                                                                                                Nicotine dependence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures - Streamlined Authority Code 6871
                                                                                                                                                                                                                               Commencement of a short-term (12 weeks or 24 weeks) course of treatment
                                                                                                                                                                                                                               The treatment must be as an aid to achieving abstinence from smoking; AND
                                                                                                                                                                                                                               The treatment must be the sole PBS-subsidised therapy for this condition; AND
                                                                                                                                                                                                                               Patient must have indicated they are ready to cease smoking; AND
                                                                                                                                                                                                                               Patient must not receive more than 24 weeks of PBS-subsidised treatment with this drug per 12-month period; AND
                                                                                                                                                                                                                               Patient must be undergoing concurrent counselling for smoking cessation through a comprehensive support and counselling program or is about to enter such a program at the time PBS-subsidised treatment is initiated.
                                                                                                                                                                                                                               Details of the support and counselling program must be documented in the patient's medical records at the time treatment is initiated.
                                                                                                                                                                                                                               Clinical review is recommended within 2 to 3 weeks of the initial prescription being requested.
C6881               P6881          CN6881           Bupropion                                                                                                                                                                  Nicotine dependence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures - Streamlined Authority Code 6881
                                                                                                                                                                                                                               Completion of a short-term (9 weeks) course of treatment
                                                                                                                                                                                                                               The treatment must be as an aid to achieving abstinence from smoking; AND
                                                                                                                                                                                                                               The treatment must be the sole PBS-subsidised therapy for this condition; AND
                                                                                                                                                                                                                               Patient must have previously received PBS-subsidised treatment with this drug during this current course of treatment; AND
                                                                                                                                                                                                                               Patient must not receive more than 9 weeks of PBS-subsidised treatment with this drug per 12-month period; AND
                                                                                                                                                                                                                               Patient must be undergoing concurrent counselling for smoking cessation through a comprehensive support and counselling program.
C6882               P6882          CN6882           Bupropion                                                                                                                                                                  Nicotine dependence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures - Streamlined Authority Code 6882
                                                                                                                                                                                                                               Commencement of a short-term (9 weeks) course of treatment
                                                                                                                                                                                                                               The treatment must be as an aid to achieving abstinence from smoking; AND
                                                                                                                                                                                                                               The treatment must be the sole PBS-subsidised therapy for this condition; AND
                                                                                                                                                                                                                               Patient